Ondas Inc

This non-binding proposal asks shareholders to approve the disclosed compensation for named executive officers, giving the Compensation Committee a stockholder-backed signal about the Company’s pay practices. Management is seeking an advisory endorsement largely because SEC rules and good governance practices require an annual Say on Pay vote, and the Compensation Committee will use the outcome to inform future decisions. The Company’s disclosed pay includes increases in base salary for the CEO and other executives in 2025, one-time discretionary bonuses, and substantial equity awards (options and RSUs) tied to hiring, retention and acquisition integration. The Board argues that equity compensation aligns executives’ interests with long-term shareholder value and is necessary given the Company’s strategic growth and acquisition activity; the Compensation Committee asserts its oversight and multi-year vesting schedules are designed to manage incentives responsibly. Notable context includes the Company’s large net losses in recent years and volatile TSR, which create potential tensions between realized pay and financial performance; the proxy includes a Pay Versus Performance disclosure showing these dynamics. Risks for shareholders include dilution from extensive equity grants and potential perceived misalignment if pay increases are not matched by improved operating results; management counters that equity is essential for retaining specialized talent and integrating acquisitions. The vote is advisory and non-binding, but a negative outcome could prompt the Compensation Committee to revise pay structures, increase disclosure, or engage with investors. Given recent significant equity plan usage and amendments, investors should weigh the company’s justification for retention and acquisition integration against dilution and pay-for-performance metrics when evaluating this proposal.

This management proposal asks shareholders to approve a 50% increase in authorized common shares from 800 million to 1.2 billion, giving the Board authority to issue up to 400 million additional shares without further stockholder approval except where law requires. Management frames the change as a governance and strategic tool to provide flexibility for acquisitions, partnerships, equity incentive awards, capital raises and other corporate needs; the Board cites a strong cash position (over $1.4 billion at March 31, 2026) and says there are no immediate plans to issue the new shares. From an analyst perspective, the amendment reduces procedural friction for future equity issuance, enabling faster execution of M&A or financing transactions, but it also creates the potential for meaningful dilution to existing shareholders and could be used opportunistically, which may depress per-share metrics and voting power if large issuances occur. The Company acknowledges dilution risk and commits the Board will consider dilutive impact relative to expected benefits, yet the amendment transfers significant discretion to the Board over capital structure decisions. Additionally, the availability of additional authorized shares can have the incidental effect of discouraging hostile bids or takeover attempts because the Board could issue shares to frustrate unsolicited offers; while management disclaims any intent to do so, this remains a governance consideration for investors. Given the Company’s recent heavy use of equity awards and restructuring related to acquisitions, investors should weigh the operational rationale against the dilution and governance trade-offs. A prudent investor evaluation will consider the Board’s stated capital allocation discipline, the company’s track record of capital deployment, and whether governance safeguards or pre-commitments (such as shareholder approval for significant issuances) accompany any future issuance plans.

This amendment seeks shareholder approval to add 20 million shares to the 2021 Stock Incentive Plan, increasing the plan’s cap from 61 million to 81 million shares (approximately 4% of shares outstanding as of the record date). Management justifies the increase on grounds of talent acquisition, retention, and especially integration of acquired companies where equity is used to align leadership and secure deals; the company notes recent, significant depletion of plan shares due to acquisition-related grants. From a governance and analytic perspective, the increase facilitates the Company’s ability to grant equity for hiring, retention, and M&A integration but raises dilution concerns given the existing large number of outstanding options and RSUs under the 2021 Plan (noted in the proxy). The Company emphasizes multi-year vesting, Compensation Committee oversight, and a commitment to disciplined equity usage, but investors should scrutinize grant-sizing, vesting schedules, burn rate, and dilution modeling to assess long-term impact. Nasdaq rules require stockholder approval for equity grants under listed-company plans, and past rapid increases to the 2021 Plan suggest continued reliance on equity as a primary compensation and integration tool. Analysts should weigh the operational need to retain specialized talent and align acquired teams against shareholder dilution, and should seek clarity on grant practices and possible guardrails (e.g., limits on repricing, awards to new acquisitions, and disclosure commitments). If approved, the amendment gives management tactical flexibility for the next two years but places the onus on the Compensation Committee to manage dilution and report on the effectiveness of grants in driving retention and value creation.